GAPP Joint Action is aiming at facilitating the development of a common and optimal approach to assess and authorize preparation processes in blood and tissues establishments.
EU-JAMRAI was a European Union Joint Action on Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HCAI) whose mission was to foster synergies among EU Member States by developing and implementing effective One Health policies to fight the rising threat of AMR and reduce HCAIs.
The Innovative Partnership for Action Against Cancer (iPAAC) Joint Action brings together 24 Associated Partners (with Affiliated Entities, 44 partners) across Europe whose main objectives are to build upon deliverables of the CANCON Joint Action and to implement innovative approaches to cancer control.
PANACEA will deliver a Dynamic Risk Management Platform, with assessment and penetration tests that support information sharing across organisational boundaries.
